Rwanda Selenium Supplementation Clinical Trial
Sponsored by The Canadian College of Naturopathic Medicine
About this trial
Last updated 13 years ago
Study ID
RCT-32122010
Status
Completed
Type
Interventional
Phase
Phase 3
Placebo
Yes
Accepting
21+ Years
All Sexes
Trial Timing
Ended 13 years ago
What is this trial about?
Study Hypothesis: The addition of selenium supplementation to cotrimoxazole will improve CD4 counts, decrease opportunistic infections, decrease viral loads and delay the need for initiating antiretroviral therapy(ART) in Rwandan adult patients infected with HIV/ AIDS.
What are the participation requirements?
Inclusion Criteria
* Patients > or = 21 years at enrollment
* Confirmed HIV positive with a CD4 range between 400 and 650 mm3
* HIV+ patients willing to participate in the study and who provide informed consent
* Pre-antiretroviral therapy (Pre-ART) at enrollment in study (not yet initiated ART)
* Willing to practice barrier method of birth control at all times
Exclusion Criteria
* Patients intending to be transferred out of the clinic catchment area before study ends
* Patients scheduled to start ART
* Moribund patients
* Pregnant women
* Unable or not wanting to commit to barrier method of birth control